Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-cancer agent.However,emergence of drug resistance limits its potential use.P
Organ-specific tumor cell adhesion to extracellular matrix (ECM) components and cell migration into host organs often involve integrin-mediated cellular process